Caraco & Watson Digoxin / Propafenone Recall Lawsuit

Tweet

Please note, Schmidt & Clark, LLP is no longer accepting Caraco claims. If you feel that you may have a potential case, we urge you to locate another law firm adequately suited to handle your claim.

Caraco Pharmaceutical Laboratories and Watson Pharmaceuticals has recalled some of their digoxin and propafenone tablets because of a variation in tablet size, which means that these products could contain more than the labeled amount of digoxin. Too much of the drug can cause digoxin toxicity and could lead to patient deaths.

June 25, 2009: U.S. Marshals Seize Drug Products Manufactured by Caraco Pharmaceutical Laboratories Ltd.

If you or a loved one has taken one of these products and subsequently suffered from an adverse event, you should contact us immediately for a free case consultation.

FDA Video: Recalls of Digoxin and Propafenone Tablets

Below is an excellent video published by the U.S. Food & Drug Administration (FDA), which warns patients and physicians of the digoxin propafenone recalls.

Link to Full Transcript: Recalls of Digoxin and Propafenone Tablets

Additional Information:

• Updated 6/29/09 – Complete Caraco Recall List
• Digoxin, USP 0.125 mg, Digoxin, USP 0.25 mg (Caraco brand)
• Propafenone HCL Tablets

Do I Have a Digoxin or Propafenone Recall Lawsuit?

The Defective Drug & Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in defective drug lawsuits. We are currently accepting new digoxin and propafenone cases in all 50 states.

If you or a loved one has taken one of these products and subsequently suffered from an adverse event, you should contact us immediately for a free case consultation.